MRNS - Marinus Pharmaceuticals, Inc. Operating income before deduction of amortization
Marinus Pharmaceuticals (MRNS) focuses on bringing orphan anticonvulsants to the clinical market. These achievements, reflected in this GURU.Markets chart of absolute operating income before depreciation, confirm an ethical culture driven by KPI bonuses. Flexibility is ensured through the outsourcing of production and trials. The current value is fixed at , allowing for a comparison of profit against retrospective data.
Marinus Pharmaceuticals, Inc. - analytical breakdowns and key metrics (MRNS)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Marinus Pharmaceuticals|MRNS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Marinus Pharmaceuticals Inc|MRNS - Company Debts|Debts to Book Capitalization Ratio Marinus Pharmaceuticals|MRNS - Company Long-Term Debts|Company Short-Term Loans and Borrowings Marinus Pharmaceuticals|Quick Ratio marinuspharma.com
- earnings and valuation multiples indicators:
MRNS - Company Net Income|Expected Net Income Marinus Pharmaceuticals|MRNS - Price to Earnings Ratio|Projected Price to Earnings marinuspharma.com|MRNS - PEG Multiple|EV/EBITDA Multiple Marinus Pharmaceuticals|MRNS - Operating profit EBITDA|Net earnings per share for the last 12 months Marinus Pharmaceuticals|MRNS - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months marinuspharma.com|MRNS - Net earnings per share growth this year|Earnings growth forecast for next year Marinus Pharmaceuticals
Analysis of all company metrics:Marinus Pharma, MRNS
The development of vital orphan drugs by Marinus Pharmaceuticals (MRNS) ensures high macro-resilience, as evidenced by the EBITDA chart through stable cash inflows. This indicator measures the daily volume of operating income before interest and amortization, allowing investors to assess the business's actual ability to act as a cash generator and service debt amid tight monetary policy.
Who Marinus Pharmaceuticals competes with
Income before deduction of interest, taxes and amortization BIIB|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ACAD|Operating profit before deduction of amortization XENE|Operating profit EBITDA Viking Therapeutics Corp|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|Operating income before deduction of amortization catalystpharma.com|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization AMLX|TRVI: Operating profit EBITDA|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|OMER - Operating profit before deduction of amortization|Neurogene - Operating profit EBITDA|ACIU - Operating profit EBITDA|VYGR: Operating profit EBITDA|Operating profit before deduction of amortization Neumora Corp|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before interest, taxes and amortization tevogen.com TVGN|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Operating profit EBITDA Cognition Therapeutics Inc. (CGTX)|Inhibikase - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAVA (Cassava Pharma)|Assertio Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics, Inc. COYA|VTGN: Operating profit EBITDA|Operating profit before deduction of amortization Ovid Therapeutics|ABOS (Acumen Pharma) - Operating profit EBITDA|Operating profit EBITDA CervoMed Corporation|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|Profit before payment of interest, taxes and amortization CLNN (clene.com)|Profit before payment of interest, taxes and amortization PepGen PEPG|Operating income before deduction of amortization Jupiter Neurosciences, Inc. (JUNS)|RLMD - Profit before payment of interest, taxes and amortization|Annovis Bio Corporation (ANVS) - Operating profit before deduction of amortization|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|fireflyneuro.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ANEW Medical|Operating profit before amortization NRSN (NeuroSense Therapeutics, Ltd.)|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|Operating income before deduction of amortization metaviatx.com|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|HSDT: Operating profit before amortization|Passage Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences Corp) - Operating profit before deduction of amortization|Athira Pharma Corp (ATHA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Addex Therapeutics|ALZN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|PTIX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Pasithea Therapeutics Corp. KTTA|CRGT - Operating profit before deduction of amortization|Avenue Therapeutics - Operating profit EBITDA|BCLI - Operating profit EBITDA|Cara Therapeutics (CARA) - Profit before payment of interest, taxes and amortization|Chromocell Therapeutics Corp - Income before deduction of interest, taxes and amortization|ELYM (Eliem Therapeutics, Inc.) - Operating profit EBITDA|Intra-Cellular (ITCI) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Longboard Pharmaceuticals (LBPH)|nkgenbiotech.com - Operating profit before amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Trevena Inc TRVN|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
